Transforming Growth Factor-β Induces Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelial Cells: Involvement of Mitogen-Activated Protein Kinases

Journal of Cellular Physiology

Volumn 197, Issue 3, 2003, Pages 453-462

  Nagineni, Chandrasekharam N ^a   Samuel, William ^a   Nagineni, Sahrudaya ^a   Pardhasaradhi, Komanduri ^b   Wiggert, Barbara ^a   Detrick, Barbara ^c   Hooks, John J ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVIN; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; PYRROLIDINE DITHIOCARBAMATE; STAUROSPORINE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN; VISUAL PIGMENT;

ARTICLE; CHOROID; CONTROLLED STUDY; DIABETIC RETINOPATHY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN SECRETION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBRETINAL NEOVASCULARIZATION;

ANTIBODIES; CELLS, CULTURED; CHOROID; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; PIGMENT EPITHELIUM OF EYE; PROTEIN ISOFORMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RETINAL DISEASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CUCUMBER NECROSIS VIRUS;

EID: 0345257178     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10378     Document Type: Article

References (66)

1. Adamis AP, Shima DT, Yeo K-T, Yeo T-K, Brown LP, Berse B, D'Amore PA, Folkman J. 1993. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun 193:631-638.
2. Adamis AP, Miller JW, Brenal M-T, D'Amico DJ, Folkman J, Yeo T-K, Yeo K-T. 1994. Increased vascular endothelial growth factor levels in the vitreos of eyes with proliferative diabetic retinopathy. Amer J Ophthalmol 118:445-450.
3. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL, 1994. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
4. Amin R, Puklin JE, Frank RN. 1994. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 35:3178-3188.
5. Arsura M, Wu M, Sonenshein GE. 1996. TGF-β1 inhibits NF-κB/ Rel activity inducing apopotosis of B cells: Transcriptional activation of IκB alpha. Immunity 5:31-40.
6. Azuma M, Motegi K, Aota K, Yamashita T, Yoshida H, Sato M. 1999. TGF-β1 inhibits NF-kappaB activity through induction of IkappaB alpha expression in human salivary gland cells: A possible mechanism of growth suppression by TGF-β1. Exp Cell Res 250:213-222.
7. Baffi J, Byrnes G, Chan CC, Csaky KG. 2000. Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. Invest Ophthalmol Vis Sci 41:3582-3589.
8. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. 2002. p38 mitogen-activated protein kinase is required for TGF-β-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115:3193-3206.
9. Beatty S, Koh H-H, Henson D, Boulton M. 2000. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115-134.
10. Blaauwgeers HGT, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, Hinsbergh VWMV, Schlingemann RO. 1999. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 155:421-428.
11. Blanchette F, Rivard N, Rudd P, Grondin F, Attisano L, Dubois CM. 2001. Cross-talk between the p42/p44 MAP kinase and smad pathways in transforming growth factor beta1-induced furin gene transactivation. J Biol Chem 276:33986-33994.
12. Bok D. 1993. The retinal pigment epithelium: a versatile partner in vision. J Cell Sci S17:189-195.
13. Borden P, Heller RA. 1997. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukar Gene Expression 7:159-178.
14. Bressler NM, Bressler SB, Fine SL. 1988. Age-related macular degeneration. Surv Ophthalmol 32:475-513.
15. Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. 1994. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 14:130-142.
16. Campochiaro PA. 2000. Retinal and choroidal neovascularization. J Cell Physiol 184:301-310.
17. Campochiaro PA, Soloway P, Ryan SJ, Miller JW. 1999. http:// www.molvis.org/molvis/v5/p34 The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vision 5:34.
18. Connor TB, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, Bustros SD, Enger C, Kato H, Lansing M, Hayashi H, Glaser BM. 1989. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J Clin Invest 83:1661-1666.
19. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breir G, Tschachler E, Albini A, Sturzl M. 1996. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 149:1851-1869.
20. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233.
21. Davies SP, Reddy H, Caivano M, Cohen P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
22. Derynck R, Feng X-H. 1997. TGF-β receptor signaling. Biochem Biophys Acta 133:F105-F150.
23. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase J Biol Chem 273:18623-18632.
24. Ferrara N. 1999. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527-543.
25. Flaumenhaft R, Kojima S, Abe M, Rifkin DB. 1993. Activation of latent transforming growth factor. Adv Pharmacol 24:51-76.
26. Frank RN. 1997. Growth factors in age-related macular degeneration: Pathogenic and therapeutic implications. Ophthalmic Res 29:341-353.
27. Green WR, Enger C. 1993. Age-related macular degeneration. Hstopathological Studies Ophthalmol 100:1519-1535.
28. Grossniklaus HE, Hutchinson AK, Capone A, Jr., Woolfson J, Lambert HM. 1994. Clinicopathologic features of surgically excised choroidal neovascuiar membranes. Opthalmology 101:1099-1111.
29. Halstead J, Kemp K, Ignotz RA. 1995. Evidence for involvement of phosphatidylcholine-Phospholipase C and protein kinase C in transforming growth factor-β signaling. J Biol Chem 270:13600-13603.
30. Hirase K, Ikeda T, Sotozono C, Nishida K, Sawa H, Kinoshita S. 1998. Transforming growth factor beta 2 in the vitreous in proliferative diabetic retinopathy. Arch Opthalmol 116:738-741.
31. Kakonen S-M, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y, Guise TA. 2002. Transforming growth factor-β stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J Biol Chem 277:24571-24578.
32. Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PTVM. 1997. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 81:154-162.
33. Korte GE, Reppucci V, Henkind P. 1984. RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci 25:1135-1145.
34. Kutty RK, Kutty G, Hooks JJ, Wiggert B, Nagineni CN. 1995. Transforming growth factor-β inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem Biophys Res Commun 215:386-393.
35. Liversidge J, Forrester JV. 1998. Regulation of immune responses by the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ, Zinn KM, Marmor MF, editors. The retinal pigment epithelium, function and disease. New York: Oxford University Press. pp 511-527.
36. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR. 1996. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 37:855-868.
37. Lutty GL, Grunwald J, Majji AB, Uyema M, Yoneya S. 1999. http:// www.molvis.org/molvis/v5/p35 Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Molecular Vision 5:35.
38. Marmor M.F, Wolfensberger TJ. 1998. The retinal pigment epithelium, function and disease. New York: Oxford University Press.
39. Massague J. 2000. How cells read TGF-β signals. Nat Rev Mol Cell Biol 1:169-178.
40. Miyazono K, ten Dijke P, Heldin CH. 2000. TGF-β signaling by smad proteins. Adv Immunol 75:115-157.
41. Mousa SA, Lorelli W, Campochiaro PA. 1999. Role of hypoxia and extracellular matrix-Integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem 74:135-143.
42. Mulder KM. 2000. Role of Ras and Mapks in TGF-β signaling. Cyto Growth Factor Rev 11:23-35.
43. Nagineni CN, Detrick B, Hooks JJ. 1994. Synergistic effects of gamma interferon on inflammatory mediators that induce interleukin-6 gene expression and secretion by human retinal pigment epithelial cells. Clin Diag Lab Immunol 1:569-577.
44. Nagineni CN, Detrick B, Hooks JJ. 2002. Transforming growth factor-β expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: A possible role in the immunopathogenesis of retinochoroiditis. Clin Exp Immunol 127:372-378.
45. Neufeld G, Cohen T, Gengrinovitch S, Poltorack Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22.
46. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores M, LaRochelle W, Zack DJ, Campochiaro PA. 1997. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281-291.
47. Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA, Oshima K. 1997. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 64:505-517.
48. Risau W, Flamme I. 1995. Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91.
49. Samuel W, Nagineni CN, Kutty RK, Parks WT, Gordon JS, Prouty SM, Hooks JJ, Wiggert B. 2002. Transforming growth factor-β regulates stearoyl coenzyme A desaturase expression through a smad signaling pathway. J Biol Chem 277:59-66.
50. Schlingemann RO, van Hinnsbergh VWM. 1997. Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol 81:501-512.
51. Seregard S, Algvere PV, Berglin L. 1994. Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes. Graefe's Arch Clin Exp Ophthalmol 232:325-329.
52. Shima DT, Deutsch U, D'Amore PA. 1995. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 370:203-208.
53. Spilsbury K, Garrett KL, Shen W-Y, Constable IJ, Rakoczy PE. 2000. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157:135-144.
54. Steinberg RH. 1985. Interactions between the retinal pigment epithelium and the neural retina. Docum Ophthalmol 60:327-346.
55. Stone J, Maslim J. 1997. Mechanisms of retinal angiogenesis. Prog Retinal Eye Res 16:157-181.
56. Tanihara H, Inatani M, Honda Y. 1997. Growth factors and their receptors in the retina and pigment epithelium. Prog Retinal Eye Res 16:271-301.
57. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954.
58. Treins C, Giorgetti-Peraldi S, Murdaca J, Obberghen EV. 2001. Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem 276:43836-43841.
59. Wakefield LM, Roberts AB. 2002. TGF-β signaling: Positive and negative effects on tumorigenesis. Curr Opinion Gen Dev 12:22-29.
60. Wang L, Zhu Y, Sharma K. 1998. Transforming growth factor-beta1 stimulates protein kinase A in mesengial cells. J Biol Chem 273:8522-8527.
61. Watanabe H, de Casesteeker MP, Yamada Y. 2001. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen activated protein kinase pathways regulates transforming growth factor-β-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276:14466-14473.
62. Wiedmann P. 1992. Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 36:373-384.
63. Xiao YQ, Malcolm K, Worthen S, Gardai S, Schiemann WP, Fadok VA, Bratton DL, Henson PM. 2002. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transformibg growth factor-β. J Biol Chem 277:14884-14893.
64. Young RW. 1987. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 31:291-306.
65. Yue J, Mulder KM. 2001. Transforming growth factor-β signal transduction in epithelial cells. Pharmacol Therapeutics 91:1-34.
66. Zarbin MA. 1998. Age-related macular degeneration: Review of pathogenesis. Eur J Ophthalmol 8:199-206.